Shalby Limited Stock Price Today (NSE: SHALBY)
Fundamental Score
Shalby Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Shalby Limited share price today is ₹153.65, down 1.04% on NSE/BSE as of 1 September 2026. Shalby Limited (SHALBY) is a Small-cap company in the Hospital sector with a market capitalisation of ₹1.82K (Cr). The 52-week high for SHALBY share price is ₹274.70 and the 52-week low is ₹125.82. At a P/E ratio of 46.24x, SHALBY is currently trading below its industry average P/E of 48.79x. The company has a Return on Equity (ROE) of 3.74% and a debt-to-equity ratio of 0.54.
Shalby Limited Share Price Chart — NSE/BSE Historical Performance
Shalby Limited share price chart: -5.38% return over the past month. 52-week high ₹274.70, 52-week low ₹125.82.
Shalby Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹153.55 | ₹156.18 | ₹151.45 | ₹153.65 | 47.39K (Cr) | |
| ₹154.42 | ₹156.79 | ₹153.02 | ₹155.27 | 51.06K (Cr) | |
| ₹155.43 | ₹157.20 | ₹152.50 | ₹154.65 | 45.66K (Cr) | |
| ₹156.92 | ₹157.79 | ₹153.50 | ₹154.33 | 50.34K (Cr) | |
| ₹154.04 | ₹157.58 | ₹153.17 | ₹156.92 | 72.77K (Cr) | |
| ₹153.00 | ₹155.39 | ₹151.50 | ₹154.69 | 65.82K (Cr) | |
| ₹153.84 | ₹158.40 | ₹153.71 | ₹154.03 | 59.12K (Cr) | |
| ₹153.70 | ₹155.75 | ₹151.83 | ₹152.96 | 55.75K (Cr) | |
| ₹155.36 | ₹157.60 | ₹153.20 | ₹154.57 | 73.22K (Cr) | |
| ₹152.00 | ₹156.87 | ₹152.00 | ₹155.45 | 72.18K (Cr) |
Shalby Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹153.55 | ₹156.18 | ₹151.45 | ₹153.65 | +0.07% | |
| ₹161.90 | ₹168.99 | ₹151.25 | ₹155.27 | -4.10% | |
| ₹175.72 | ₹176.88 | ₹160.00 | ₹161.30 | -8.21% | |
| ₹168.81 | ₹182.27 | ₹162.03 | ₹175.72 | +4.09% | |
| ₹161.00 | ₹180.70 | ₹152.41 | ₹168.81 | +4.85% | |
| ₹133.40 | ₹169.90 | ₹129.69 | ₹160.66 | +20.43% | |
| ₹151.00 | ₹154.00 | ₹125.82 | ₹126.80 | -16.03% | |
| ₹166.15 | ₹182.70 | ₹151.00 | ₹154.83 | -6.81% | |
| ₹204.93 | ₹207.00 | ₹160.40 | ₹168.15 | -17.95% | |
| ₹209.98 | ₹211.68 | ₹186.75 | ₹203.93 | -2.88% | |
| ₹241.25 | ₹252.05 | ₹206.35 | ₹208.93 | -13.40% | |
| ₹266.45 | ₹273.00 | ₹235.35 | ₹241.30 | -9.44% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Shalby Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Shalby Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SHALBY across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Strong Operating Margins (16.76%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Robust Profit Growth (21.58%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Consistent Growth Track Record (22.21% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Balanced Promoter Holding (74.33%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
8 factors identified
Below-Average Return on Equity (3.74%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (7.93%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 46.24x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Weak Earnings Growth (-4.04% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-2.70% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Negative Free Cash Flow (₹-259.54 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 4.77%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Shalby Limited vs Hospital Peers
Peer Comparison - Hospital
Compare Shalby Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Shalby LimitedShalby Limited...Selected✓ SHALBY • 540797 | 38.3/100 | ₹153.65₹154 | ₹1817.71₹1817.71 | 46.24Average 46.2 Average | 3.74%Poor 3.74% Poor | 7.93%Poor 7.93% Poor | 0.54Good 0.5 Good | -2.70%Poor -2.70% Poor | 22.21%Excellent 22.21% Excellent | 0.00% |
Apollo Hospitals Enterprise LimitedApollo Hospital... APOLLOHOSP • 508869 | 62.1/100 | ₹8889.00₹8889 | ₹128448.55₹128448.55 | 61.47Average 61.5 Average | 21.95%Excellent 21.95% Excellent | 19.28%Good 19.28% Good | 0.60Good 0.6 Good | 66.81%Excellent 66.81% Excellent | 19.03%Excellent 19.03% Excellent | 0.22% |
Max Healthcare Institute LimitedMax Healthcare ... MAXHEALTH • 543220 | 56.9/100 | ₹1016.00₹1016 | ₹107422.79₹107422.79 | 73.71Average 73.7 Average | 14.33%Average 14.33% Average | 13.43%Average 13.43% Average | 0.32Excellent 0.3 Excellent | — — | 27.30%Excellent 27.30% Excellent | 0.18% |
Fortis Healthcare LimitedFortis Healthca... FORTIS • 532843 | 56.8/100 | ₹923.95₹924 | ₹73687.64₹73687.64 | 70.32Average 70.3 Average | 11.08%Average 11.08% Average | 12.83%Average 12.83% Average | 0.29Excellent 0.3 Excellent | — — | 17.76%Excellent 17.76% Excellent | 0.10% |
Aster DM Quality Care LimitedAster DM Qualit... ASTERDM • 540975 | 37.2/100 | ₹765.25₹765 | ₹71917.90₹71917.90 | 225.67Average 225.7 Average | 9.70%Poor 9.70% Poor | 11.35%Average 11.35% Average | 0.15Excellent 0.2 Excellent | 21.31%Excellent 21.31% Excellent | -11.61%Poor -11.61% Poor | 0.61% |
Narayana Hrudayalaya Ltd.Narayana Hruday... NH • 539551 | 68.3/100 | ₹1890.10₹1890 | ₹41592.95₹41592.95 | 50.96Average 51.0 Average | 19.74%Good 19.74% Good | 14.53%Average 14.53% Average | 1.07Average 1.1 Average | — — | 25.05%Excellent 25.05% Excellent | 0.22% |
Global Health LimitedGlobal Health L... MEDANTA • 543654 | 59.9/100 | ₹1404.40₹1404 | ₹35993.93₹35993.93 | 64.72Average 64.7 Average | 15.15%Good 15.15% Good | 16.85%Good 16.85% Good | 0.30Excellent 0.3 Excellent | — — | — — | 0.04% |
13.9/100 | ₹772.50₹773 | ₹33947.05₹33947.05 | 166.00Average 166.0 Average | 11.01%Average 11.01% Average | 9.35%Poor 9.35% Poor | 1.44Average 1.4 Average | 3.71%Average 3.71% Average | 24.04%Excellent 24.04% Excellent | 0.00% | |
Dr. Agarwal's Health Care LimitedDr. Agarwal's H... AGARWALEYE • 544350 | 48.5/100 | ₹500.40₹500 | ₹15618.15₹15618.15 | 105.26Average 105.3 Average | 6.84%Poor 6.84% Poor | 10.16%Average 10.16% Average | 0.08Excellent 0.1 Excellent | — — | — — | 0.00% |
Rainbow Childrens Medicare LimitedRainbow Childre... RAINBOW • 543524 | 65.5/100 | ₹1445.20₹1445 | ₹15270.28₹15270.28 | 53.51Average 53.5 Average | 17.86%Good 17.86% Good | 18.10%Good 18.10% Good | 0.00Excellent 0.0 Excellent | — — | — — | 0.23% |
60/100 | ₹298.70₹299 | ₹9829.95₹9829.95 | 52.28Average 52.3 Average | 13.41%Average 13.41% Average | 15.25%Good 15.25% Good | 0.33Excellent 0.3 Excellent | — — | — — | 0.07% | |
Top Hospital Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Apollo Hospitals Enterprise Limited share price128448.55 Cr
- Max Healthcare Institute Limited share price107422.79 Cr
- Fortis Healthcare Limited share price73687.64 Cr
- Aster DM Quality Care Limited share price71917.90 Cr
- Narayana Hrudayalaya Ltd. share price41592.95 Cr
Shalby Limited PE Ratio History
Historical price-to-earnings ratio for SHALBY — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹0.18 | ₹203.93 | 1132.9x |
| FY 2024 | ₹7.77 | ₹229.65 | 29.6x |
| FY 2023 | ₹6.30 | ₹302.60 | 48x |
| FY 2022 | ₹5.00 | ₹150.75 | 30.2x |
| FY 2021 | ₹3.97 | ₹140.95 | 35.5x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Shalby Limited Dividend History
Annual cash dividends paid by SHALBY — dividend yield N/A
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹12.96 Cr |
| FY 2024 | ₹12.96 Cr |
| FY 2023 | ₹10.80 Cr |
| FY 2022 | ₹10.80 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Shalby Limited Quarterly Performance
Latest quarterly metrics for SHALBY — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
11.74%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
21.58%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
22.21%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-2.70%
Compounded annual net profit growth over 5 years
Shalby Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SHALBY — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Shalby Limited Financial Statements
Annual income statement, balance sheet and cash flow for Shalby Limited (SHALBY) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Shalby Limited
About SHALBY (Shalby Limited)
Shalby Ltd is a prominent healthcare institution recognized for its comprehensive and patient-centric approach. Founded on the principles of ethical and transparent medical practic...es, Shalby has evolved into a network of state-of-the-art hospitals equipped with cutting-edge technology and staffed by a team of highly skilled medical professionals. The hospital's architecture blends modern design with a calming atmosphere, aiming to alleviate patient anxiety and foster a sense of well-being. Shalby distinguishes itself by prioritizing individualized treatment plans, ensuring that each patient receives tailored care that addresses their unique needs and medical history. From advanced diagnostic imaging to minimally invasive surgical techniques, Shalby is committed to delivering world-class medical solutions. Beyond its medical expertise, Shalby emphasizes holistic care, recognizing the importance of emotional and psychological support in the healing process. The hospital environment is designed to promote relaxation and recovery, featuring comfortable accommodations, serene gardens, and dedicated spaces for patient and family interaction. Shalby's commitment to patient satisfaction extends beyond clinical treatments, encompassing personalized attention, clear communication, and a supportive network of caregivers. The hospital also actively engages in community outreach programs, promoting health awareness and providing access to medical services for underserved populations. This dedication to social responsibility underscores Shalby's commitment to improving the overall health and well-being of the communities it serves. Shalby's reputation as a center of medical excellence is built upon its commitment to innovation, research, and continuous improvement. The hospital invests heavily in developing new medical technologies and treatment protocols, fostering a culture of innovation among its staff. Shalby actively participates in clinical trials and research studies, contributing to the advancement of medical knowledge and pushing the boundaries of healthcare. Furthermore, the hospital's commitment to education and training ensures that its medical professionals remain at the forefront of their respective fields. This unwavering dedication to quality and innovation solidifies Shalby's position as a leading healthcare provider, dedicated to providing patients with the best possible medical outcomes.
Company Details
Key Leadership
Corporate Events
Latest News
SHALBY Share Price: Frequently Asked Questions
What is the current share price of Shalby Limited?
Shalby Limited (SHALBY) trades at ₹153.65 on NSE and BSE. Market cap ₹1.82K (Cr). Educational data only.
What is the P/E ratio of Shalby Limited?
Shalby Limited has a P/E of 46.24x vs industry average 48.79x.
What is the Bull Run score for Shalby Limited?
Shalby Limited has a Bull Run score of 38.3/100 based on 25+ financial parameters.
Does Shalby Limited pay dividends?
Shalby Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Shalby Limited?
Shalby Limited has ROE of 3.74%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Shalby Limited?
Shalby Limited has debt-to-equity of 0.54.
Is Shalby Limited a good investment?
Bull Run gives Shalby Limited a score of 38.3/100. This is not investment advice — consult a SEBI-registered advisor.